- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 100.06M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 100.06M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 100.06M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $130.34K |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $139.65K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $11.1K |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$290.33K |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$156.86K |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$166.58K |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $619.67K |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $890.08K |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $965.53K |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.24M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $788.77K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $745.78K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $976.63K |
| Total Assets | Q1 2026 · Dec 31, 2025 | $949.05K |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.00 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $178.29K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $147.72K |
| Net Income | Q1 2026 · Mar 31, 2026 | $301.43K |
| Net Income | Q1 2026 · Mar 31, 2025 | $9.71K |
| Operating Income | Q1 2026 · Mar 31, 2026 | $303.63K |
| Operating Income | Q1 2026 · Mar 31, 2025 | $11.91K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $698.29K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $256.08K |
| Revenue | Q1 2026 · Mar 31, 2026 | $2.38M |
| Revenue | Q1 2026 · Mar 31, 2025 | $780.5K |